We are live on ! Find out more
XBIT icon

XBiotech
XBIT

66 hedge funds and large institutions have $56.7M invested in XBiotech in 2021 Q3 according to their latest regulatory filings, with 12 funds opening new positions, 29 increasing their positions, 10 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

500% more first-time investments, than exits

New positions opened: 12 | Existing positions closed: 2

190% more repeat investments, than reductions

Existing positions increased: 29 | Existing positions reduced: 10

18% more funds holding

Funds holding: 56 → 66 (+10)

1.78% more ownership

Funds ownership: 13.71% → 15.49% (+1.8%)

15% less capital invested

Capital invested by funds: $66.6M → $56.7M (-$9.94M)

98% less call options, than puts

Call options by funds: $8K | Put options by funds: $452K

Holders
66
Holders Change
+10
Holders Change %
+17.86%
% of All Funds
1.16%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
12
Increased
29
Reduced
10
Closed
2
Calls
$8K
Puts
$452K
Net Calls
-$444K
Net Calls Change
-$76K

Top Buyers

Rank Fund Capital Flow
1
OIM
Oracle Investment Management
Connecticut
+$5.58M
2
Citadel Advisors
Citadel Advisors
Florida
+$762K
3
HF
HRT Financial
New York
+$571K
4
Vanguard Group
Vanguard Group
Pennsylvania
+$535K
5
Northern Trust
Northern Trust
Illinois
+$467K

Top Sellers

Rank Fund Capital Flow
1
Wells Fargo
Wells Fargo
California
-$1M
2
N
Nuveen
North Carolina
-$563K
3
CS
Credit Suisse
Switzerland
-$350K
4
PPA
Parametric Portfolio Associates
Washington
-$348K
5
JP Morgan Chase
JP Morgan Chase
New York
-$99.1K
Name Holding Trade Value Shares
Change 		Change in
Stake
BNP Paribas Financial Markets
51
BNP Paribas Financial Markets
France
$59.7K +$28.5K +1,787 +63%
MLICM
52
Metropolitan Life Insurance Company (MetLife)
New York
$57.7K +$71K +4,457 New
Citigroup
53
Citigroup
New York
$47K +$12.3K +775 +27%
Royal Bank of Canada
54
Royal Bank of Canada
Ontario, Canada
$43K +$3.9K +245 +8%
Zurich Cantonal Bank
55
Zurich Cantonal Bank
Switzerland
$27K – – –
Group One Trading
56
Group One Trading
Illinois
$26K +$32.2K +2,024 New
AIP
57
Ameritas Investment Partners
Nebraska
$15K – – –
Russell Investments Group
58
Russell Investments Group
United Kingdom
$13K – – –
TRCT
59
Tower Research Capital (TRC)
New York
$10K -$11.2K -704 -47%
ME
60
McIlrath & Eck
Washington
$10K – – –
IA
61
IFP Advisors
Florida
$9K – – –
PCM
62
Penserra Capital Management
California
$9K +$159 +10 +1%
Canada Life
63
Canada Life
Manitoba, Canada
$8K – – –
US Bancorp
64
US Bancorp
Minnesota
$6K – – –
Daiwa Securities Group
65
Daiwa Securities Group
Japan
$1K – – –
Nisa Investment Advisors
66
Nisa Investment Advisors
Missouri
$52 +$63.7K +4,000 New
PPA
67
Parametric Portfolio Associates
Washington
– -$348K -20,995 Closed
ASN
68
Advisory Services Network
Georgia
– -$3K -200 Closed
1 2
3

XBIT Hedge Fund Activity: Q3 2021 in Review

66 of the 5,712 institutional investors tracked by Wall St. Rank reported a position in XBiotech (XBIT) for Q3 2021, worth a combined $56.7M — down 15% from $66.6M a quarter earlier.

Buyers outnumbered sellers: 12 funds opened new XBIT positions and 2 closed out — a net gain of 10 holders — while 29 added to existing stakes and 10 trimmed.

The largest buyer was Oracle Investment Management, opening a new position worth an estimated $5.58M. The largest seller was Wells Fargo, cutting an estimated $1M.

  • 66 institutional investors held XBiotech (XBIT) as of Q3 2021, up from 56 in Q2 2021.
  • Funds reported $56.7M of XBiotech stock for Q3 2021, down 15% quarter-over-quarter.
  • 12 funds opened new XBiotech positions in Q3 2021 and 2 closed out, a net change of +10 holders.
  • The largest XBiotech buyer in Q3 2021 was Oracle Investment Management, an estimated $5.58M added.
  • The largest XBiotech seller in Q3 2021 was Wells Fargo, an estimated $1M sold.

Based on aggregated 13F filings for Q3 2021.